ab25388 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab25388 は 16 報の論文で使用されています。

  • Mück F  et al. DDX6 transfers P-TEFb kinase to the AF4/AF4N (AFF1) super elongation complex. Am J Blood Res 6:28-45 (2016). PubMed: 27679741
  • Albert TK  et al. The Establishment of a Hyperactive Structure Allows the Tumour Suppressor Protein p53 to Function through P-TEFb during Limited CDK9 Kinase Inhibition. PLoS One 11:e0146648 (2016). PubMed: 26745862
  • Flynn RA  et al. 7SK-BAF axis controls pervasive transcription at enhancers. Nat Struct Mol Biol 23:231-8 (2016). PubMed: 26878240
  • Liu L  et al. Transcriptional pause release is a rate-limiting step for somatic cell reprogramming. Cell Stem Cell 15:574-88 (2014). WB . PubMed: 25312495
  • Kuzmina A  et al. A single point mutation in cyclin T1 eliminates binding to Hexim1, Cdk9 and RNA but not to AFF4 and enforces repression of HIV transcription. Retrovirology 11:51 (2014). WB . PubMed: 24985467
  • Liu P  et al. Release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein (snRNP) activates hexamethylene bisacetamide-inducible protein (HEXIM1) transcription. J Biol Chem 289:9918-25 (2014). WB, ChIP ; Human . PubMed: 24515107
  • Safronova OS  et al. Acute hypoxia affects P-TEFb through HDAC3 and HEXIM1-dependent mechanism to promote gene-specific transcriptional repression. Nucleic Acids Res 42:8954-69 (2014). IP, ICC/IF ; Human . PubMed: 25056306
  • Dhanda J  et al. SERPINE1 and SMA expression at the invasive front predict extracapsular spread and survival in oral squamous cell carcinoma. Br J Cancer 111:2114-21 (2014). IHC . PubMed: 25268377
  • Bartholomeeusen K  et al. Histone deacetylase inhibitors (HDACis) that release the positive transcription elongation factor b (P-TEFb) from its inhibitory complex also activate HIV transcription. J Biol Chem 288:14400-7 (2013). WB, IP ; Mouse . PubMed: 23539624
  • Cherrier T  et al. CTIP2 is a negative regulator of P-TEFb. Proc Natl Acad Sci U S A 110:12655-60 (2013). PubMed: 23852730
  • Shishido T  et al. Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation. J Virol 86:9055-69 (2012). PubMed: 22696646
  • Bartholomeeusen K  et al. Bromodomain and Extra-terminal (BET) Bromodomain Inhibition Activate Transcription via Transient Release of Positive Transcription Elongation Factor b (P-TEFb) from 7SK Small Nuclear Ribonucleoprotein. J Biol Chem 287:36609-16 (2012). WB, IP . PubMed: 22952229
  • Benedikt A  et al. The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures. Leukemia 25:135-44 (2011). WB, IP ; Human . PubMed: 21030982
  • Lin C  et al. AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia. Mol Cell 37:429-37 (2010). PubMed: 20159561
  • Urano E  et al. Identification of the P-TEFb complex-interacting domain of Brd4 as an inhibitor of HIV-1 replication by functional cDNA library screening in MT-4 cells. FEBS Lett 582:4053-8 (2008). WB ; Human . PubMed: 18996376
  • Elagib KE  et al. Cross-talk of GATA-1 and P-TEFb in megakaryocyte differentiation. Blood 112:4884-94 (2008). WB ; Human . PubMed: 18780834